5,6-Dichloropyrazine-2,3-dicarbonitrile

Catalog No. :
ACZDUR049
CAS No. :
56413-95-7
Molecular Formula :
C6Cl2N4
Molecular Weight :
199

IUPAC Name:5,6-dichloropyrazine-2,3-dicarbonitrile

5,6-Dichloropyrazine-2,3-dicarbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g96%$84.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5,6-Dichloropyrazine-2,3-dicarbonitrile
IUPAC Name5,6-dichloropyrazine-2,3-dicarbonitrile
MDL No.MFCD00191419
Molecular FormulaC6Cl2N4
Molecular Weight199
SMILESN#CC1=NC(Cl)=C(Cl)N=C1C#N
InChI KeyQUFXYBKGILUJHS-UHFFFAOYSA-N
SynonymD2271 | AKOS005363154 | MFCD00191419 | FT-0619816 | 2,3-dichloro-5,6-dicyanopyrazine | 5,6-Dichloro-2,3-pyrazinedicarbonitrile # | R10017 | DTXSID30345890 | AMY41047 | 5,6-dichloropyrazine-2,3-dicarbonitrile | Z99599896 | 2,3-Pyrazinedicarbonitrile, 5,6-d
CAS No.56413-95-7
PubChem CID607820

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301+H311+H331-H315-H319
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P310+P330-P302+P352+P312-P304+P340+P311-P305+P351+P338-P332+P313-P337+P313-P361+P364-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACZDUR049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLQYC064 route compound structure diagram
    ACLQYC06430818-40-7 In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACZDUR049 route product structure diagram
    ACZDUR04956413-95-7 In Stock
Inquiry

2. ACZDUR049 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1 In Stock
  4. Then
  5. ACZDUR049 route product structure diagram
    ACZDUR04956413-95-7 In Stock
Inquiry

Comments (0)